Skip to main content

The Growth-Regulatory Role of p21 (WAF1/CIP1)

  • Chapter
Inhibitors of Cell Growth

Part of the book series: Progress in Molecular and Subcellular Biology ((PMSB,volume 20))

Abstract

Cyclin kinase inhibitors (CKIs) are proteins that bind to and inhibit the activity of cyclin-dependent kinases (Cdks). One of the first of these to be identified was p21, which binds and inhibits G, cyclin/Cdk complexes (Harper et al. 1993; Xiong et al. 1993). The p21 cDNA was cloned independently by several groups using a number of different screening strategies. It was identified as the product of a gene activated by wild-type p53, and it was named WAF1 (wild-type p53-activated factor (E1-Deiry et al. 1993). Microsequencing of a protein that interacted with Cdks led to its cloning using PCR (Xiong et al. 1993). Using a yeast two-hybrid screen, it was also identified as a Cdk-binding protein, and was subsequently named CIP1, for Cdk-interacting protein 1 (Harper et al. 1993). p21 was cloned using an expression screen designed to identify inhibitors of DNA synthesis from senescent fibroblasts, and it was named SDI1 (senescent cell-derived inhibitor (Noda et al. 1994). Using subtractive hybridization, the p21 cDNA was also isolated based on its increased expression in human melanoma cells that were induced to differentiate, and it was termed MDA-6, for melanoma differentiation associated protein (Jiang et al. 1994).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adachi J, Ookawa K, Shiseki M, Okazaki T, Tsuchida S, Morishita K, Yokota J (1996) Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma. Cell Growth Differ 7: 879–886

    PubMed  CAS  Google Scholar 

  • Adachi Y, Laemmli UK (1994) Study of the cell cycle-dependent assembly of the DNA pre-replication centres in Xenopus egg extracts. EMBO J 13: 4153–4164

    PubMed  CAS  Google Scholar 

  • Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin W Jr (1996) Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol 16: 6623–6633

    PubMed  CAS  Google Scholar 

  • Afshari CA, Nichols MA, Xiong Y, Mudryl M (1996) A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Differ 7: 979–988

    PubMed  CAS  Google Scholar 

  • Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S (1997) G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cipl/WAFT/Sdil in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res 57: 1495–1501

    PubMed  CAS  Google Scholar 

  • Albrecht JH, Meyer AH, Hu MY (1997) Regulation of cyclin-dependent kinase inhibitor p21 (WAF1/Cipl/Sdi1) gene expression in hepatic regeneration. Hepatology 25: 557–563

    Google Scholar 

  • Aprelikova O, Xiong Y, Liu ET (1995) Both p16 and p21 families of cyclin dependent kinase inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem 270: 18195–18197

    Article  PubMed  CAS  Google Scholar 

  • Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A, Keyomarsi K (1996) Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 12: 2535–2547

    PubMed  CAS  Google Scholar 

  • Bae I, Fan S, Bhatia K, Kohn KW, Fornace AJ, O’Connor PM (1995) Relationships between G1 arrest and stability of the p53 and p21Cipl/Wafl proteins following gamma-irradiation of human lymphoma cells. Cancer Res 5585: 2387–2393

    Google Scholar 

  • Balbin M, Hannon GJ, Pendas AM, Ferrando AA, Vizoso F, Fueyo A, Lopez-Otin C (1996) Functional analysis of a p21 WAFT, CIP1, SDI1 mutant (Arg94–Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclindependent kinases. J Biol Chem 271: 15782–15786

    Article  PubMed  CAS  Google Scholar 

  • Bates S, Bonetta L, Macallan D, Parry D, Holder A, Dickson C, Peters G (1994) CDK6 and CDK4 are distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9: 71–79

    PubMed  CAS  Google Scholar 

  • Biggs JR, Kudlow JE, Kraft AS (1996) The role of the transcription factor Sp1 in regulating the expression of the WAFT/CIP1 gene in U937 leukemic cells. J Biol Chem 271: 901–906

    Article  PubMed  CAS  Google Scholar 

  • Billon N, van Grunsven LA, Rudkin BB (1996) The CDK inhibitor p21WAF1/Cipl is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13: 2047–2054

    PubMed  CAS  Google Scholar 

  • Boudreau N, Werb Z, Bissell MJ (1996) Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci USA 93: 3509–3513

    Article  PubMed  CAS  Google Scholar 

  • Brown JP, Wei W, Sedivy JM (1997) Bypass of senescence after disrupton of p21c`p’IWAFI gene in normal diploid human fibroblasts. Science 277: 831–834

    Article  PubMed  CAS  Google Scholar 

  • Brugarolas J, Chadrasekaran C, Gordon J, Beach D, Jacks T, Hannon G (1995) Radiation-inuced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557

    Article  PubMed  CAS  Google Scholar 

  • Bukholm IK, Nesland JM, Karesen R, Jacobsen U, Borresen AL (1997) Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol 181: 140–145

    Article  PubMed  CAS  Google Scholar 

  • Canman CE, Gilmer TM, Coutts SB, Kastan MB (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9: 600–611

    Article  PubMed  CAS  Google Scholar 

  • Cardoso MC, Leonhardt H, Nadal-Ginard B (1993) Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74: 979–992

    Article  PubMed  CAS  Google Scholar 

  • Cayrol C, Flemington EK (1996) The Epstin-Barr virus bZIP transcription factor Zta causes GO/ G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J 15: 2748–2759

    PubMed  CAS  Google Scholar 

  • Chan FK, Zhang J, Cheng L, Shapiro DN, Winoto A (1995) Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to pl6ink4. Mol Cell Biol 15: 2682–2688

    PubMed  CAS  Google Scholar 

  • Chedid M, Michieli P, Lengel C, Huppi K, Givol D (1994) A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIPI. Oncogene 9: 3021–3024

    PubMed  CAS  Google Scholar 

  • Chen IT, Smith ML, O’Connor PM, Fornance All (1995) Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 with p21Wafu“`P1 with PCNA. Oncogene 11: 1931–1937

    PubMed  CAS  Google Scholar 

  • Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace A Jr, O’Connor PM (1996) Characterization of p21Cip1/Wafl peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12: 595–607

    PubMed  CAS  Google Scholar 

  • Chen J, Jackson PK, Kirschner MW, Dutta A (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386–388

    Article  PubMed  CAS  Google Scholar 

  • Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A (1996) Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol 16: 4673–4682

    PubMed  CAS  Google Scholar 

  • Chen W, Ko LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apopotic response of tumor cells. Genes Dev 10: 2438–2451

    Google Scholar 

  • Chen X, Bargonetti J, Prives C (1995) p53, through p21(WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 55: 4257–4263

    PubMed  CAS  Google Scholar 

  • Chen U, Chen S, Saha P, Dutta A (1996) p21 Cipl/Wafl disrupts the recruitment of human Fenl by proliferating-cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci USA 93(21):11597–11602

    Article  PubMed  CAS  Google Scholar 

  • Chen YQ, Cipriano SC, Arenkiel JM, Miller FR (1995) Tumor suppression by p21 (WAF1) Cancer Res 55: 4536–4539

    CAS  Google Scholar 

  • Chin YE, Kitagawa M, Su W-CS, You Z-H, Iwamoto Y, Fu X-Y (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIPI mediated by STATI. Science 272: 719–722

    Article  PubMed  CAS  Google Scholar 

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature 362: 849–852

    Article  PubMed  CAS  Google Scholar 

  • Clarke AR, Gledhill S, Hoper ML, Bird CC, Wyllie AH (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma irradiation. Oncogene 9: 1767–1773

    PubMed  CAS  Google Scholar 

  • Datto M, Li Y, Panus J, Howe D, Xiong Y, Wang X (1995a) Transforming growth factor (3 induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92: 5545–5549

    Article  PubMed  CAS  Google Scholar 

  • Datto MB, Yu Y, Wang X-F (1995b) Functional analysis of the transforming growth factor beta-responsive elements in the WAF1/Cipl/p21 promoter. J Biol Chem 270: 28623–28628

    Article  PubMed  CAS  Google Scholar 

  • Datto MB, Hu PP, Kowalik TF, Yingling J, Wang XF (1997) The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cipl and p15/INK4B. Mol Cell Biol 17: 2030–2037

    PubMed  CAS  Google Scholar 

  • Decker SJ (1995) Nerve growth factor-induced growth arrest and induction of p21 Cipl/Wafl in NIH-3T3 Cells expressing TrkA. J Biol Chem 270: 30841–30844

    Article  PubMed  CAS  Google Scholar 

  • Deng C, Zhang P, Harper J, Elledge S, Leder P (1995) Mice lacking p21 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684

    Article  PubMed  CAS  Google Scholar 

  • de Nooij JC, Hariharan IK (1995) Uncoupling cell fate determination from patterned cell division in the Drosophila eye. Science 270: 983–985

    Article  PubMed  Google Scholar 

  • Derynck R (1994) TGF-13-receptor-mediated signaling. TIBS 19: 548–553

    PubMed  CAS  Google Scholar 

  • Dimri GP, Nakanishi M, Desprez PY, Smith JR, Campisi J (1996) Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 16: 2987–2997

    PubMed  CAS  Google Scholar 

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215–221

    Article  PubMed  CAS  Google Scholar 

  • Dulic V, Lees E, Reed S (1992) Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958–1961

    CAS  Google Scholar 

  • Dulic V, Kaufman WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced GI arrest. Cell 76: 1013–1023

    Article  PubMed  CAS  Google Scholar 

  • Duttaroy A, Qian JF, Smith JS, Wang E (1997) Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J Cell Biochem 64: 434–446

    Article  PubMed  CAS  Google Scholar 

  • Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L, Elledge SJ, Zhang WW, Harper JW, Thompson TC (1995) In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 55: 5151–5155

    PubMed  CAS  Google Scholar 

  • Elbendary E (1994) Transforming growth factor 13 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 5: 1301–1307

    PubMed  CAS  Google Scholar 

  • El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, Lin D, Mercer W, Kinzler K, Vogelstein B (1993) WAFT, a potential mediator of p53 tumor suppression. Cell 75: 817–825

    Google Scholar 

  • El-Deity WS, Tokino T, Waldman T, Oliner JD, Velculscu VE, Burrel M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B (1995) Topological control of p21 (WAF1/CIP1) expression in normal and neoplastic tissues. Cancer Res 55: 2910–2919

    Google Scholar 

  • Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA (1997) Induction of p21 by the Wilms’ tumor suppressor gene WT1. Cancer Res 57: 1429–1434

    PubMed  CAS  Google Scholar 

  • Fang F, Newport JW (1993) Distinct roles of cdk2 and cdc2 in RP-A phosphorylation during the cell cycle. J Cell Sci 106: 983–994

    PubMed  CAS  Google Scholar 

  • Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O’Donnell MO, Hurwitz J (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymeras delta holoenzyme. Proc Natl Acad Sci USA 91: 8655–8659

    Article  PubMed  CAS  Google Scholar 

  • Furutani M, Arii S, Tanaka H, Mise M, Niwano M, Harada T, Higashitsuji H, Imamura M, Fujita J (1997) Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma. Cancer Lett 111: 191–197

    Article  PubMed  CAS  Google Scholar 

  • Gao X, Chen YQ, Wu N, Grignon DJ, Sakr W, Porter AT, Honn KV (1995) Somatic mutations of the WAF1/CIP1 gene in primary prostate canner. Oncogene 11: 1395–1398

    PubMed  CAS  Google Scholar 

  • Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, El-Deiry WS, Tyner AL (1996) p21 (WAF1/ CIP1) expression is induced in newly nondividing cells in diverse epithelial and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 227: 171–181

    Google Scholar 

  • Gartenhaus RB, Wang P, Hoffmann P (1996) Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc Natl Acad Sci USA 93: 265–268

    Article  PubMed  CAS  Google Scholar 

  • Gibbs E, Kelman Z, Gulbis JM, O’Donnell M, Kuriyan J, Burgers P, Hurwitz J (1997) The influence of the proliferating cell nuclear antigen-interacting domain of p21 (CIP1) on DNA synthesis catalyzed by the human and Saccharomyces cerevisiae polymerase delta holoenzymes. J Biol Chem 272: 2373–2381

    Article  PubMed  CAS  Google Scholar 

  • Gorospe M, Shack S, Guyton K, Samid D, Holbrook N (1996a) Up-regulation and functional role of p21 (WAF1/CIPI) during growth arrest of human breast carcinima MCF-7 cells by phenylacetate. Cell Growth Differ 7: 1609–1615

    PubMed  CAS  Google Scholar 

  • Gorospe M, Wang X, Guyton K, Holbrook N (1996b) Protective role of p21 (WAF1/CIP1) against prostaglandin A2-mediated apoptosis of human colorectal carcinima cells. Mol Cell Biol 16: 6654–6660

    PubMed  CAS  Google Scholar 

  • Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi M, Holbrook N (1997) P21 (WAF1/CIP1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929–935

    Article  PubMed  CAS  Google Scholar 

  • Gotz C, Wagner P, Issinger OG, Montenarh M (1996) p21 WAF1/CIP1 interacts with protein kinase CK2. Oncogene 13: 391–398

    PubMed  CAS  Google Scholar 

  • Gudas J, Nguyen H, Li T, Hill D, Cowan K (1995) Effects of cell cycle, wild-type p53 and DNA damage on p21 CIP1/WAF1 expression in human breast epithelial cells. Oncogene 11: 253–261

    PubMed  CAS  Google Scholar 

  • Guerra B, Gotz C, Wagner P, Montenarh M, Issinger OG (1997) The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation. Oncogene 14: 2683–2688

    Article  PubMed  CAS  Google Scholar 

  • Gulbis JM, Kelman Z, Hurwitz J, O’Donnell M, Kuriyan J (1996) Structure of the C-terminal region of p21 (WAF1/CIP1) complexed with human PCNA. Cell 87: 297–306

    Article  PubMed  CAS  Google Scholar 

  • Halevy 0, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995) Correlation of terminal cell-cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021

    Article  PubMed  Google Scholar 

  • Hall M, Bates S, Peteres G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11: 1581–1588

    PubMed  CAS  Google Scholar 

  • Hannon GJ, Beach D (1994) p15iok4b is a potential effector of cell cycle arrest mediated by TGF-(3. Nature 371: 257–261

    Article  PubMed  CAS  Google Scholar 

  • Harper JW, Adami G, Wei N, Keyomarsi K, Elledge S (1993) The p21 cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816

    Article  PubMed  CAS  Google Scholar 

  • Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai L, Zhang P, Dobtowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387–400

    PubMed  CAS  Google Scholar 

  • Harvey M, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A, Donehower LA (1993) Sponta- neous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 5: 225–229

    Article  PubMed  CAS  Google Scholar 

  • Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ (1995) Novel INK4 proteins, p19 and pl 8, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15: 2672–2681

    PubMed  CAS  Google Scholar 

  • Hitomi M, Shu J, Strom D, Hiebert SW, Harter ML, Stacey DW (1996) Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J Biol Chem 271: 9376–9383

    Article  PubMed  CAS  Google Scholar 

  • Hiyama H, Iavarone A, LaBaer J, Reeves SA (1997) Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell-cycle progression. Oncogene 14: 2533–2542

    Article  PubMed  CAS  Google Scholar 

  • Ho YS, Wang YJ, Lin JK (1996) Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinogen 16: 20–31

    Article  CAS  Google Scholar 

  • Hobeika AC, Subramaniam PS, Johnson HM (1997) IFNalpha induces the expression of the cyclin- dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene 14: 1165–1170

    Article  PubMed  CAS  Google Scholar 

  • Hollenstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutation in human cancer. Science 253: 49–53

    Article  Google Scholar 

  • Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC, Fontana JA (1997) Retinoid-induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89: 4470–4479

    PubMed  CAS  Google Scholar 

  • Hui AM, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S (1997) Reduced p21 (WAFT/CIPI) expression and p53 mutation in hepatocellular carcinomas. Hepatology 25: 575–579

    Article  PubMed  CAS  Google Scholar 

  • Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D, Mushinski JF (1994) Molecular cloning, sequencing, chromosomal location and expression of mouse p21 ( Waft ). Oncogene 9: 3017–3020

    PubMed  CAS  Google Scholar 

  • Ihle JN (1996) STATs and MAPKs: obligate or opportunistic partners in signaling. Bioessays 18: 95–98

    Article  PubMed  CAS  Google Scholar 

  • Iida S, Fujii H, Moriwaki K (1997) A somatic mutation of the p21 ( Wafl/Cipl) gene in a human adrenocortical adenoma. Anticancer Res 17: 633–636

    PubMed  CAS  Google Scholar 

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1–7

    Article  PubMed  CAS  Google Scholar 

  • Jackson PK, Chevalier S, Philippe M, Kirschner MW (1995) Early events in DNA replication require cycin E and are blocked by p21. J Cell Biol 130: 755–769

    CAS  Google Scholar 

  • Jakus J, Yeudall WA (1996) Growth inhibitory concentrations of EGF induce p21 (WAF1/Cipl) and alter cell cycle control in squamous carcinoma cells. Oncogene 12: 2369–2376

    PubMed  CAS  Google Scholar 

  • Jeoung DI, Tang B, Sonenberg M (1995) Induction of tumor suppressor p21 protein by kinase inhibitors in MCF-7 cells. Biochem Biophys Res Commun 214: 361–366

    Article  PubMed  CAS  Google Scholar 

  • Jiang H, Iiu J, Su Z, Collart F, Huberman E, Fisher P (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397–3406

    PubMed  CAS  Google Scholar 

  • Jiang H, Lin J, Su Z, Herlyn M, Kerbel R, Weissman B, Welch D, Fisher P (1995) The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10: 1855–1864

    PubMed  CAS  Google Scholar 

  • Johnson M, Dimitrov D, Vojta P, Barrett J, Noda A, Pereira-Smith O, Smith J (1994) Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF!/p21 RNA in human cells. Mol Carcinogen 11: 59–64

    Article  CAS  Google Scholar 

  • Jung J-M, Bruner JM, Ruan S, Langford LA, Kyritis AP, Kobayashi T, Levin VA, Zhang W (1995) Increased levels of p21WAP’“’P’ in human brain tumors. Oncogene 11: 2021–2028

    PubMed  CAS  Google Scholar 

  • Kamb A, Gruis N, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian S, Stockert E, Day III R, Johnson B, Skolnick M (1994) A cell-cycle regulator involved in genesis of many tumor types. Science 264: 436–440

    Article  PubMed  CAS  Google Scholar 

  • Katayose D, Wersto R, Cowan K, Seth P (1995) Consequences of p53 gene Expression by adenovirus vector on cell-cycle arrest and apoptosis in human aortic vascular smooth muscle cells. Biochem Biophys Res Commun 215: 446–451

    Article  PubMed  CAS  Google Scholar 

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA (1995) Gadd45 is a nuclear cell-cycleregulated protein which interacts with p21`’P’. Oncogene 11: 1675–1681

    PubMed  CAS  Google Scholar 

  • Kelman Z (1997) PCNA: structure, functions and interactions. Oncogene 14: 629–640

    Article  PubMed  CAS  Google Scholar 

  • Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH (1996) WAF1/CIP1 increases the susceptibility of p53 nonfunctional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13: 1279–1285

    PubMed  CAS  Google Scholar 

  • Koopman J, Maintz D, Schild S, Schramm J, Lousi DN, Wiestler OD, von Deimling A (1995) Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumors. Br J Cancer 72: 1230–1233

    Article  Google Scholar 

  • Law JC, Deka A (1995) Identification of a PstI polymorphism in the p21 Cipl/Wafl cyclindependent kinase inhibitor gene. Hum Genet 95: 459–460

    Article  PubMed  CAS  Google Scholar 

  • Lee M, Reynisdottir I, Massague J (1995) Cloning of p57, a cyclin-dependent kinase inhibitor with unique domain structue and tissue distribution. Genes Dev 9: 639–649

    Article  PubMed  CAS  Google Scholar 

  • Li R, Waga S, Hannon G, Beach D, Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA dependent DNA replication and repair. Nature 371: 534–537

    Article  PubMed  CAS  Google Scholar 

  • Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R (1995) Polymorphisms and probable lack of mutation in the WAF1–CIP1 gene in colorectal cancer. Oncogene 10: 599–601

    PubMed  CAS  Google Scholar 

  • Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM (1997) Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823–827

    Article  PubMed  CAS  Google Scholar 

  • Lin J, Reichner C, Wu X, Levine AI (1996) Analysis of wild-type and mutant p21’ gene activities. Mol Cell Biol 16: 1786–1793

    PubMed  CAS  Google Scholar 

  • Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM (1996) A reversible, p53-dependent GO/ GI cell-cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 10: 934–947

    Article  PubMed  CAS  Google Scholar 

  • Liu M, Javarone A, Freedman LP (1996a) Transcriptional activation of the human p21 (WAF1/ CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271: 31723–31728

    Article  PubMed  CAS  Google Scholar 

  • Liu M, Lee M-H, Cohen M, Bommakanti M, Freedman LP (1996b) Transcriptional activation of the Cdk inhibitor p21 by vitamin D, leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142–153

    Article  PubMed  CAS  Google Scholar 

  • Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H (1997) Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 11: 663–677

    Article  PubMed  CAS  Google Scholar 

  • Lowe SW, Schmidt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362: 847–849

    Article  PubMed  CAS  Google Scholar 

  • Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF (1997) WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Am J Pathol 150: 167–175

    PubMed  CAS  Google Scholar 

  • Luo Y, Hurwitz J, Massague J (1995) Cell-cycle inhibition by independent CDK and PCNA binding domains in p21. Nature 375: 159–161

    Article  PubMed  CAS  Google Scholar 

  • Macleod K, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T (1995) p53-dependent and -independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935–944

    Article  PubMed  CAS  Google Scholar 

  • Macleod KF, Hu Y, Jacks T (1996) Loss of Rb activates both p53-dependent and -independent cell death pathways in the developing mouse nervous system. EMBO J 15: 6178–6188

    PubMed  CAS  Google Scholar 

  • Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dalla Palma P, Bevilacqua G (1996) p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 12: 1319–1324

    PubMed  CAS  Google Scholar 

  • Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y (1997) Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21 (WAF1/ Cip1) by STAT5. Mol Cell Biol 17: 2933–2943

    PubMed  CAS  Google Scholar 

  • Matsuoka S, Edwards M, Bai C, Parker S, Zhang P, Baldini A, Harper J, Elledge S (1995) p57, a structurally distinct member of the p21 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9: 650–662

    Google Scholar 

  • McDonald ER 3rd, Wu GS, Waldman T, El-Deiry WS (1996) Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res 56: 2250–2255

    PubMed  CAS  Google Scholar 

  • Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA (1994) The role of p53 in spontaneous and radiation-induced apapotosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 5420: 614–617

    Google Scholar 

  • Michieli P, Chedid D, Lin D, Pierce J, Mercer W, Givol D (1994) Inhibition of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391–3395

    PubMed  CAS  Google Scholar 

  • Missero C, Calautti E, Eckner R, Chin J, Tsai L, Livingston D, Dotto GP (1995) Involvement of the cell-cycle inhibitor Cipl/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92: 5451–5455

    Article  PubMed  CAS  Google Scholar 

  • Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP (1996) The absence of p21Cipl/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10: 3065–3075

    Article  PubMed  CAS  Google Scholar 

  • Morgan DO (1995) Principles of CDK regulation. Nature 374: 131–134

    Article  PubMed  CAS  Google Scholar 

  • Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL (1995) Two variants of the CIP1/ WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 4: 1089–1092

    Article  PubMed  CAS  Google Scholar 

  • Nakanishi M, Adami G, Robetorye R, Noda A, Venable S, Dimitrov D, Pereira-Smith 0, Smith J (1995a) Exit from Go and entry into the cell cycle of cells expressing p21 antisense RNA. Proc Natl Acad Sci USA 92: 4352–4356

    Article  PubMed  CAS  Google Scholar 

  • Nakanishi M, Robetorye RS, Adami R, Pereira-Smith OM, Smith JR (1995b) Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J 14: 555–563

    PubMed  CAS  Google Scholar 

  • Namba H, Hara T, Tukazaki T, Migita K, Ishikawa N, Ito K, Nagataki S, Yamashita S (1995) Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cipl pathway in human thyroid cells. Cancer Res 55: 2075–2080

    PubMed  CAS  Google Scholar 

  • Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell- derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90–98

    Article  PubMed  CAS  Google Scholar 

  • Pan ZQ, Reardon JT, L. L, Flores-Rozas H, Legerski R, Sancar A, Hurwitz J (1995) Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem 270: 22008–22016

    Article  PubMed  CAS  Google Scholar 

  • Papandreou CN, Bogenrieder T, Loganzo F, Albino AP, Nanus DM (1997) Expression and sequence analysis of the p21 (WAFT/CIP1) gene in renal cancers. Urology 49: 481–486

    Article  PubMed  CAS  Google Scholar 

  • Parker S, Eichele G, Zhang P, Rawls A, Sands A, Bradley A, Olson E, Harper J, Elledge S (1995) p53-independent expression of p21 in muscle and other terminally differentiating cells. Science 267: 1024–1027

    Article  CAS  Google Scholar 

  • Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523–527

    Article  PubMed  CAS  Google Scholar 

  • Podust VN, Podust LM, Goubin F, Ducommun B, Hubscher U (1995) Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34: 8869–8875

    Article  PubMed  CAS  Google Scholar 

  • Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH (1996) The cyclin-dependent kinase inhibitor p21 ( WAFT) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16: 1335–1341

    Google Scholar 

  • Polyak K, Lee M, Erdjument-Bromage H, Koff A, Roberts J, Tempst P, Massague J (1994) Cloning of p27, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66

    Article  PubMed  CAS  Google Scholar 

  • Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945–1952

    Article  PubMed  CAS  Google Scholar 

  • Prowse DM, Bolgan L, Molnar A, Dotto GP (1997) Involvement of the Sp3 transcription factor in induction of p2lCipl/WAF1 in keratinocyte differentiation. J Biol Chem 272: 1308–1314

    Article  PubMed  CAS  Google Scholar 

  • Pumiglia KM, Decker SJ (1997) Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94: 448–452

    Article  PubMed  CAS  Google Scholar 

  • Reynisdottir I, Polyak K, Iavorne A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooper-ate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9: 1831–1845

    Article  PubMed  CAS  Google Scholar 

  • Reznitzky D, Reed S (1995) Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15: 3463–3469

    Google Scholar 

  • Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, Clarke MF (1994) c-myc and bc12 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci 91: 5878–5882

    Article  PubMed  CAS  Google Scholar 

  • Saeed Sheikh M, Garcia M, Zhan Q, Liu Y, Fornace AJJ (1996) Cell cycle-independent regulation of p21(WAF1/CIPI) and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Cell Growth Differ 7: 1599–1607

    Google Scholar 

  • Saha P, Eichbaum Q, Siberman ED, Mayer BJ, Dutta A (1997) p21 (Cipl) and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol 17: 4338–4345

    PubMed  CAS  Google Scholar 

  • Sangfelt O, Erickson S, Einhorn S, Grander D (1997) Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene 14: 415–423

    Article  PubMed  CAS  Google Scholar 

  • Scheffner M, Huibregste JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495–505

    Article  PubMed  CAS  Google Scholar 

  • Schmid P, Lorenz A, Hameister H, Montenarh M (1991) Expression of p53 during mouse embryo-genesis. Development 113: 857–865

    PubMed  CAS  Google Scholar 

  • Serfas MS, Goufman E, Feuerman MH, Gartel AL, Tyner AL (1997) p53-independent induction of p21wAnicIPI expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ 8: 951–961

    PubMed  CAS  Google Scholar 

  • Serrano M, Hannon G, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/cdk4. Nature 366: 704–707

    Article  PubMed  CAS  Google Scholar 

  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes prema- ture cell senescence associated with accumulation of p53 and pl6INK4a. Cell 88: 593–602

    Article  PubMed  CAS  Google Scholar 

  • Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA (1995) p53-independent GO/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493–504

    PubMed  CAS  Google Scholar 

  • Sherr C, Roberts J (1995) Inhibitors of mammalian GI cyclin-dependent kinases. Genes Dev 9: 1149–1163

    Article  PubMed  CAS  Google Scholar 

  • Shi Y, Zou M, Farid NR, al-Sedairy ST (1996) Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br J Cancer 74: 1336–1341

    Article  PubMed  CAS  Google Scholar 

  • Shim J, Lee H, Park J, Kim H, Choi E (1996) A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381: 804–807

    Article  PubMed  CAS  Google Scholar 

  • Shimizu T, Miwa W, Nakamori S, Ishikawa O, Konishi Y, Sekiya T (1996) Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers. Jpn J Cancer Res 87: 275–278

    Article  PubMed  CAS  Google Scholar 

  • Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 8484: 3781–3784

    Google Scholar 

  • Shiohara M, Akashi M, Gombart A, Yang R, Koeffler H (1996) Tumor necrosis factor alpha: posttanscriptional stabilization of WAFT mRNA in p53-deficient human leukemic cells. J Cell Physiol 166: 568–576

    Article  PubMed  CAS  Google Scholar 

  • Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ (1994) Cipl inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr Biol 4: 1062–1068

    Article  PubMed  CAS  Google Scholar 

  • Shiyanov P, Bagchi S, Adami G, Kokontis J, Hay N, Arroyo M, Morozov A, Raychaudhuri P (1996) p21 disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol 16: 737–744

    PubMed  CAS  Google Scholar 

  • Skapek SX, Rhee J, Spicer DB, Lassar AB (1995) Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022–1024

    Article  PubMed  CAS  Google Scholar 

  • Steinman R, Hoffman B, Iro A, Guillouf C, Liebermann D, El-Houseini M (1994) Induction of p21(WAF-1/CIP1) during differentiation. Oncogene 9: 3389–3396

    PubMed  CAS  Google Scholar 

  • Strasberg Rieber M, Welch DR, Miele ME, Rieber M (1996) p53-independent increase in p21 WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells. Cell Growth Differ 7: 197–202

    PubMed  CAS  Google Scholar 

  • Su WC, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA, Fu XY (1997) Activation of Stat 1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386: 288–292

    Article  PubMed  CAS  Google Scholar 

  • Tevosian SG, Shih HH, Mendelson KG, Sheppard KA, Paulson KE, Yee AS (1997) HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev 11: 383–396

    Article  PubMed  CAS  Google Scholar 

  • Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ (1996) CCAAT/enhancerbinding protein a (C/EBPa) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10: 804–815

    Article  PubMed  CAS  Google Scholar 

  • Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 78: 67–74

    Article  PubMed  CAS  Google Scholar 

  • Trotter MJ, Tang L, Tron VA (1997) Overexpression of the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma. J Cutan Pathol 24: 265–271

    Article  PubMed  CAS  Google Scholar 

  • Tsao YP, Li LY, Tsai TC, Chen SL (1996) Human papillomavirus type 11 and 16 E5 represses p21 ( WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. J Virol 70: 7535–7539

    PubMed  CAS  Google Scholar 

  • Tsumanuma I, Tanaka R, Abe S, Kawasaki T, Washiyama K, Kumanishi T (1997) Infrequentmutation of Wafl/p21 gene, a CDK inhibitor gene, in brain tumors. Neurol Med Chir 37: 150–156

    Article  CAS  Google Scholar 

  • Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, Liskay RM, Kunkel TA (1996) Require-ment for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87: 65–73

    Article  PubMed  CAS  Google Scholar 

  • Upadhyay S, Li G, Liu H, Chen YQ, Sarkar FH, Kim H-RC (1995) bd-2 suppresses expression of p21wAmcrP1 in breast epithelial cells. Cancer Res 55: 4520–4524

    PubMed  CAS  Google Scholar 

  • Vidal MJ, Loganzo F Jr, de Oliveira AR, Hayward NK, Albino AP (1995) Mutations and defective expression of the WAFT p21 tumour-suppressor gene in malignant melanomas. Melanoma Res 5: 243–250

    Article  PubMed  CAS  Google Scholar 

  • Waga S, Hannon G, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574–578

    Article  PubMed  CAS  Google Scholar 

  • Waldman T, Kinzler KW, Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187–5190.

    Google Scholar 

  • Wang A, Yoshimi N, Ino N, Tanaka T, Mori H (1997) WAFI expression and p53 mutations in human colorectal cancers. J Cancer Res Clin Oncol 123: 118–123

    Article  PubMed  CAS  Google Scholar 

  • Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yahalom J, Wieder R (1997) Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory GI events. Cancer Res 57: 1750–1757

    PubMed  CAS  Google Scholar 

  • Wang J, Walsh K (1996) Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science 273: 359–361

    Article  PubMed  CAS  Google Scholar 

  • Wang J, Guo K, Wills KN, Walsh K (1997) Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57: 351–354

    PubMed  CAS  Google Scholar 

  • Warbrick E, Lane DP, Glover DM, Cox LS (1995) A small peptide inhibitor of DNA replication defines the site of interatction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr Biol 5: 275–282

    Article  PubMed  CAS  Google Scholar 

  • Warbrick E, Lane DP, Glover DM, Cox LS (1997) Homologous regions of Fenl and p21Cipl compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair. Oncogene 14: 2313–2321

    Article  PubMed  CAS  Google Scholar 

  • Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T (1996) Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev 10: 245–260

    Article  PubMed  CAS  Google Scholar 

  • Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704

    Article  PubMed  CAS  Google Scholar 

  • Yamato K, Koseki T, Ohguchi M, Kizaki M, Ikeda Y, Nishihara T (1997) Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells. Mol Endocrinol 11: 1044–1052

    Article  PubMed  CAS  Google Scholar 

  • Yan H, Newport J (1995) An analysis of the regulation of DNA synthesis by cdk2, Cipl, and licensing factor. J Cell Biol 129: 1–15

    Article  PubMed  CAS  Google Scholar 

  • Yang ZY, Perkins ND, Ohno T, Nabel EG, Nabel GJ (1995) The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1: 1052–1056

    Article  PubMed  CAS  Google Scholar 

  • Yonish-Rouach E (1996) The p53 tumour-suppressor gene: a mediator of a G1 growth arrest and of apoptosis. Experientia 52: 1001–1007

    Article  PubMed  CAS  Google Scholar 

  • Yoshida K, Murohashi I, Hirashima K (1996) p53-independent induction of p21 (WAF1/CIP1) during differentiation of HL-60 cells by tumor necrosis factor alpha. Int J Hematol 65: 41–48

    Article  PubMed  CAS  Google Scholar 

  • Zakut R, Givol D (1995) The tumor suppression function of p21 Waf is contained in its N-terminal half (“half-WAF”). Oncogene 11: 393–395

    PubMed  CAS  Google Scholar 

  • Zeng YX, El-Deiry WS (1996) Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557–1564

    PubMed  CAS  Google Scholar 

  • Zeng YX, Somasundaram K, El-Deiry WS (1997) AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nature Genet 15: 78–82

    Article  PubMed  CAS  Google Scholar 

  • Zhang H, Xiong Y, Beach D (1993) Proliferating cell nuclear anitgen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4: 897–906

    PubMed  CAS  Google Scholar 

  • Zhang H, Hannon G, Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750–1758

    Article  PubMed  CAS  Google Scholar 

  • Zhang W, Grasso L, McClain C, Gambel A, Cha Y, Travali S, Deisseroth A, Mercer W (1995) p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668–674

    PubMed  CAS  Google Scholar 

  • Zhu L, Harlow E, Dynlacht BD (1995) p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate intractions with E2F. Genes Dev 9: 1740–1752

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gartel, A.L., Tyner, A.L. (1998). The Growth-Regulatory Role of p21 (WAF1/CIP1). In: Macieira-Coelho, A. (eds) Inhibitors of Cell Growth. Progress in Molecular and Subcellular Biology, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72149-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72149-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72151-9

  • Online ISBN: 978-3-642-72149-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics